MASP1 and glomerular disorder: Despite having significantly less albuminuria and pathological features of glomerular disease in the Masp1/3−/− MRL/lpr mice, the absence of MASP-1/3 had no significant beneficial effect on survival in the MRL/lpr mice until the time of sacrifice (week 24) (Figure 8).